Eldehna et al. synthesized a series of amido/ureido-tethered isatin-benzene sulfonamide hybrids and evaluated the in vitro inhibitory activity against a panel of hCA I and II (cytosolic) and IX and XII (transmembrane, tumour-associated) isoforms. The gene discussed is CYP24A1; the disease is neoplasm.